GIVAUDAN-REG (GIN.DE) Fundamental Analysis & Valuation

FRA:GIN • CH0010645932

Current stock price

3403 EUR
+4 (+0.12%)
Last:

This GIN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. GIN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year GIN was profitable.
  • GIN had a positive operating cash flow in the past year.
  • GIN had positive earnings in each of the past 5 years.
  • GIN had a positive operating cash flow in each of the past 5 years.
GIN.DE Yearly Net Income VS EBIT VS OCF VS FCFGIN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

  • GIN's Return On Assets of 9.70% is amongst the best of the industry. GIN outperforms 91.55% of its industry peers.
  • The Return On Equity of GIN (26.64%) is better than 95.77% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 14.53%, GIN belongs to the top of the industry, outperforming 94.37% of the companies in the same industry.
  • GIN had an Average Return On Invested Capital over the past 3 years of 11.27%. This is above the industry average of 7.00%.
  • The last Return On Invested Capital (14.53%) for GIN is above the 3 year average (11.27%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.7%
ROE 26.64%
ROIC 14.53%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.27%
ROIC(5y)10.89%
GIN.DE Yearly ROA, ROE, ROICGIN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • The Profit Margin of GIN (14.51%) is better than 92.96% of its industry peers.
  • GIN's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 18.93%, GIN belongs to the top of the industry, outperforming 90.14% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GIN has grown nicely.
  • GIN has a Gross Margin (44.13%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of GIN has grown nicely.
Industry RankSector Rank
OM 18.93%
PM (TTM) 14.51%
GM 44.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
GIN.DE Yearly Profit, Operating, Gross MarginsGIN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

5

2. GIN.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GIN is creating value.
  • GIN has about the same amout of shares outstanding than it did 1 year ago.
  • GIN has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for GIN has been reduced compared to a year ago.
GIN.DE Yearly Shares OutstandingGIN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
GIN.DE Yearly Total Debt VS Total AssetsGIN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 4.47 indicates that GIN is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.47, GIN belongs to the top of the industry, outperforming 84.51% of the companies in the same industry.
  • GIN has a debt to FCF ratio of 4.31. This is a neutral value as GIN would need 4.31 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.31, GIN belongs to the top of the industry, outperforming 84.51% of the companies in the same industry.
  • GIN has a Debt/Equity ratio of 0.91. This is a neutral value indicating GIN is somewhat dependend on debt financing.
  • GIN has a Debt to Equity ratio of 0.91. This is in the lower half of the industry: GIN underperforms 74.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 4.31
Altman-Z 4.47
ROIC/WACC3.21
WACC4.52%
GIN.DE Yearly LT Debt VS Equity VS FCFGIN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

  • GIN has a Current Ratio of 1.38. This is a normal value and indicates that GIN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.38, GIN is doing worse than 69.01% of the companies in the same industry.
  • GIN has a Quick Ratio of 1.38. This is a bad value and indicates that GIN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GIN's Quick ratio of 0.85 is on the low side compared to the rest of the industry. GIN is outperformed by 67.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.85
GIN.DE Yearly Current Assets VS Current LiabilitesGIN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

3

3. GIN.DE Growth Analysis

3.1 Past

  • GIN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.21%.
  • Measured over the past 5 years, GIN shows a small growth in Earnings Per Share. The EPS has been growing by 6.04% on average per year.
  • GIN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.93%.
  • GIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.63% yearly.
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%

3.2 Future

  • GIN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.41% yearly.
  • The Revenue is expected to grow by 4.33% on average over the next years.
EPS Next Y3.35%
EPS Next 2Y3.34%
EPS Next 3Y4.29%
EPS Next 5Y4.41%
Revenue Next Year1.48%
Revenue Next 2Y2.36%
Revenue Next 3Y3.19%
Revenue Next 5Y4.33%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GIN.DE Yearly Revenue VS EstimatesGIN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
GIN.DE Yearly EPS VS EstimatesGIN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50 100 150

3

4. GIN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 24.94, which indicates a rather expensive current valuation of GIN.
  • The rest of the industry has a similar Price/Earnings ratio as GIN.
  • GIN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.78, which is the current average of the S&P500 Index.
  • GIN is valuated rather expensively with a Price/Forward Earnings ratio of 23.44.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GIN is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. GIN is around the same levels.
Industry RankSector Rank
PE 24.94
Fwd PE 23.44
GIN.DE Price Earnings VS Forward Price EarningsGIN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • GIN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. GIN is more expensive than 70.42% of the companies in the same industry.
  • 66.20% of the companies in the same industry are more expensive than GIN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.91
EV/EBITDA 18.5
GIN.DE Per share dataGIN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • GIN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)7.44
PEG (5Y)4.13
EPS Next 2Y3.34%
EPS Next 3Y4.29%

6

5. GIN.DE Dividend Analysis

5.1 Amount

  • GIN has a Yearly Dividend Yield of 2.46%. Purely for dividend investing, there may be better candidates out there.
  • GIN's Dividend Yield is a higher than the industry average which is at 2.30.
  • Compared to an average S&P500 Dividend Yield of 1.83, GIN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.46%

5.2 History

  • The dividend of GIN has a limited annual growth rate of 2.57%.
Dividend Growth(5Y)2.57%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 58.96% of the earnings are spent on dividend by GIN. This is a bit on the high side, but may be sustainable.
  • GIN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.96%
EPS Next 2Y3.34%
EPS Next 3Y4.29%
GIN.DE Yearly Income VS Free CF VS DividendGIN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIN.DE Dividend Payout.GIN.DE Dividend Payout, showing the Payout Ratio.GIN.DE Dividend Payout.PayoutRetained Earnings

GIN.DE Fundamentals: All Metrics, Ratios and Statistics

GIVAUDAN-REG

FRA:GIN (1/23/2026, 7:00:00 PM)

3403

+4 (+0.12%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-29
Earnings (Next)04-14
Inst Owners35.71%
Inst Owner ChangeN/A
Ins Owners12.15%
Ins Owner ChangeN/A
Market Cap31.41B
Revenue(TTM)7.54B
Net Income(TTM)1.09B
Analysts74.29
Price Target4402.24 (29.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.46%
Yearly Dividend74.21
Dividend Growth(5Y)2.57%
DP58.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 24.94
Fwd PE 23.44
P/S 3.82
P/FCF 25.91
P/OCF 19.89
P/B 7
P/tB N/A
EV/EBITDA 18.5
EPS(TTM)136.44
EY4.01%
EPS(NY)145.16
Fwd EY4.27%
FCF(TTM)131.33
FCFY3.86%
OCF(TTM)171.09
OCFY5.03%
SpS891.99
BVpS485.93
TBVpS-49.69
PEG (NY)7.44
PEG (5Y)4.13
Graham Number1221.37
Profitability
Industry RankSector Rank
ROA 9.7%
ROE 26.64%
ROCE 16.77%
ROIC 14.53%
ROICexc 15.06%
ROICexgc 33.58%
OM 18.93%
PM (TTM) 14.51%
GM 44.13%
FCFM 14.72%
ROA(3y)8.16%
ROA(5y)7.72%
ROE(3y)22.13%
ROE(5y)21.72%
ROIC(3y)11.27%
ROIC(5y)10.89%
ROICexc(3y)12.1%
ROICexc(5y)11.55%
ROICexgc(3y)26.29%
ROICexgc(5y)25.18%
ROCE(3y)13.01%
ROCE(5y)12.57%
ROICexgc growth 3Y11.26%
ROICexgc growth 5Y9.01%
ROICexc growth 3Y9.76%
ROICexc growth 5Y7.13%
OM growth 3Y4.7%
OM growth 5Y4.36%
PM growth 3Y6.18%
PM growth 5Y5.38%
GM growth 3Y1.09%
GM growth 5Y1.59%
F-Score8
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 4.31
Debt/EBITDA 2.08
Cap/Depr 91.06%
Cap/Sales 4.46%
Interest Coverage 15.68
Cash Conversion 80.51%
Profit Quality 101.46%
Current Ratio 1.38
Quick Ratio 0.85
Altman-Z 4.47
F-Score8
WACC4.52%
ROIC/WACC3.21
Cap/Depr(3y)97.93%
Cap/Depr(5y)83.59%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.45%
Profit Quality(3y)99.97%
Profit Quality(5y)111.02%
High Growth Momentum
Growth
EPS 1Y (TTM)4.21%
EPS 3Y11.12%
EPS 5Y6.04%
EPS Q2Q%0.69%
EPS Next Y3.35%
EPS Next 2Y3.34%
EPS Next 3Y4.29%
EPS Next 5Y4.41%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y3.51%
Revenue growth 5Y3.63%
Sales Q2Q%3.4%
Revenue Next Year1.48%
Revenue Next 2Y2.36%
Revenue Next 3Y3.19%
Revenue Next 5Y4.33%
EBIT growth 1Y12.19%
EBIT growth 3Y8.37%
EBIT growth 5Y8.14%
EBIT Next Year28.11%
EBIT Next 3Y11.5%
EBIT Next 5Y8.76%
FCF growth 1Y57.67%
FCF growth 3Y8.88%
FCF growth 5Y10.3%
OCF growth 1Y24.98%
OCF growth 3Y8.06%
OCF growth 5Y7.42%

GIVAUDAN-REG / GIN.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GIVAUDAN-REG?

ChartMill assigns a fundamental rating of 5 / 10 to GIN.DE.


Can you provide the valuation status for GIVAUDAN-REG?

ChartMill assigns a valuation rating of 3 / 10 to GIVAUDAN-REG (GIN.DE). This can be considered as Overvalued.


What is the profitability of GIN stock?

GIVAUDAN-REG (GIN.DE) has a profitability rating of 9 / 10.


What is the valuation of GIVAUDAN-REG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GIVAUDAN-REG (GIN.DE) is 24.94 and the Price/Book (PB) ratio is 7.


What is the earnings growth outlook for GIVAUDAN-REG?

The Earnings per Share (EPS) of GIVAUDAN-REG (GIN.DE) is expected to grow by 3.35% in the next year.